Rod vision begins when 11-cis-retinal absorbs a photon and isomerizes to all-trans-retinal (ATR) within the photopigment, rhodopsin. Photoactivated rhodopsin triggers an enzyme cascade that lowers the concentration of cGMP, thereby closing cyclic nucleotide–gated (CNG) ion channels. After isomerization, ATR dissociates from rhodopsin, and after a bright light, this release is expected to produce a large surge of ATR near the CNG channels. Using excised patches from Xenopus oocytes, we recently showed that ATR shuts down cloned rod CNG channels, and that this inhibition occurs in the nanomolar range (aqueous concentration) at near-physiological concentrations of cGMP. Here we further characterize the ATR effect and present mechanistic information. ATR was found to decrease the apparent cGMP affinity, as well as the maximum current at saturating cGMP. When ATR was applied to outside-out patches, inhibition was much slower and less effective than when it was applied to inside-out patches, suggesting that ATR requires access to the intracellular surface of the channel or membrane. The apparent ATR affinity and maximal inhibition of heteromeric (CNGA1/CNGB1) channels was similar to that of homomeric (CNGA1) channels. Single-channel and multichannel data suggest that channel inhibition by ATR is reversible. Inhibition by ATR was not voltage dependent, and the form of its dose–response relation suggested multiple ATR molecules interacting per channel. Modeling of the data obtained with cAMP and cGMP suggests that ATR acts by interfering with the allosteric opening transition of the channel and that it prefers closed, unliganded channels. It remains to be determined whether ATR acts directly on the channel protein or instead alters channel–bilayer interactions.
Skip Nav Destination
Article navigation
1 May 2004
Article Contents
Article|
April 12 2004
All-trans-retinal Is a Closed-state Inhibitor of Rod Cyclic Nucleotide–gated Ion Channels
Sarah L. McCabe,
Sarah L. McCabe
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Search for other works by this author on:
Diana M. Pelosi,
Diana M. Pelosi
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Search for other works by this author on:
Michelle Tetreault,
Michelle Tetreault
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Search for other works by this author on:
Andrew Miri,
Andrew Miri
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Search for other works by this author on:
Wang Nguitragool,
Wang Nguitragool
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Search for other works by this author on:
Pranisa Kovithvathanaphong,
Pranisa Kovithvathanaphong
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Search for other works by this author on:
Rahul Mahajan,
Rahul Mahajan
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Search for other works by this author on:
Anita L. Zimmerman
Anita L. Zimmerman
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Search for other works by this author on:
Sarah L. McCabe
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Diana M. Pelosi
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Michelle Tetreault
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Andrew Miri
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Wang Nguitragool
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Pranisa Kovithvathanaphong
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Rahul Mahajan
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Anita L. Zimmerman
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI 02912
Address correspondence to Anita L. Zimmerman, Box G-B329, Brown University, Providence, RI 02912. Fax: (401) 863-1222; email: [email protected]
Abbreviations used in this paper: ATR, all-trans-retinal; CNG, cyclic nucleotide–gated; IRBP, interphotoreceptor retinoid binding protein.
Received:
December 31 2003
Accepted:
March 08 2004
Online ISSN: 1540-7748
Print ISSN: 0022-1295
The Rockefeller University Press
2004
J Gen Physiol (2004) 123 (5): 521–531.
Article history
Received:
December 31 2003
Accepted:
March 08 2004
Citation
Sarah L. McCabe, Diana M. Pelosi, Michelle Tetreault, Andrew Miri, Wang Nguitragool, Pranisa Kovithvathanaphong, Rahul Mahajan, Anita L. Zimmerman; All-trans-retinal Is a Closed-state Inhibitor of Rod Cyclic Nucleotide–gated Ion Channels . J Gen Physiol 1 May 2004; 123 (5): 521–531. doi: https://doi.org/10.1085/jgp.200409011
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Two Temporal Phases of Light Adaptation in Retinal Rods
J Gen Physiol (January,2002)
The Limit of Photoreceptor Sensitivity : Molecular Mechanisms of Dark Noise in Retinal Cones
J Gen Physiol (May,2005)
Recoverin Regulates Light-dependent Phosphodiesterase Activity in Retinal Rods
J Gen Physiol (June,2004)
Email alerts
Advertisement